Janssen's Rybrevant yields positive data

Results from trial showed a long-term response among specific lung cancer population - News - PharmaTimes

Related Keywords

Denmark ,Martin Vogel ,Janssen Cilag Gmb ,Pilar Garrido ,European Lung Cancer Congress ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Pharmaceutical Companies ,Lung Cancer Congress ,Janssen Cilag Gmbh ,Universidad De Alcal ,Janssen ,Rybrevant ,Data ,